| Product Name |
CAS No |
Final API |
| N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine |
923036-30-0 |
Tofacitinib |
| N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine |
477600-73-0 |
| 2-[4-(bromomethyl)phenyl]benzonitrile |
114772-54-2 |
Azilsartan |
| Methyl 2-ethoxybenzimidazole-7-carboxylate |
150058-27-8 |
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-
2-ethoxy-1H-benzimidazole-7-carboxylate |
139481-44-0 |
| Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate |
139481-41-7 |
| 1,2,3,4-tetrahydro-naphthoic acid |
1914-65-4 |
Palonosetron |
| 2-(4-chlorophenyl)ethanol |
1875-88-3 |
Lorcaserin HCl |
| 2-(4-Chlorophenyl)ethylamine |
156-41-2 |
| ((R )-1-aminopropan-2-ol) |
2799-17-9 |
| 1-[[2-(4-Chlorophenyl)ehyl]amino]-2-chloropropane hydrochloride |
953789-37-2 |
| 4-hydroxybenzenepropanoic acid[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl] methylester |
144256-11-1 |
Landiolol HCL |
| (2S)-( )-glycidyl-3-nitrobenzensulfonate |
115314-14-2 |
(1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-
bicyclo[4.1.0]hept-3-ene-3-carboxylate(SHEP) |
204254-96-6 |
Oseltamivir |
IMEE :
4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester |
144689-93-0 |
medoxomil-Cl :4-Chloromethyl-5-methyl
-1,3-dioxol-2-one |
80841-78-7 |
| Regorafenib hydrate |
755037-03-7 |
Regorafenib |
| 2-(N-Methylcaramoyl)-4-chloropyridine |
220000-87-3 |
| 2-Fluoro-4-hydroxyaniline |
399-95-1 |
| 1-Chloro-4-isocyanato-2-(trifluoromethyl)benzene |
327-78-6 |
| 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester |
178306-47-3 |
Ambrisentan |
| 4,6-Dimethyl-2-(methylsulfonyl)pyrimidine |
35144-22-0 |
| (R)-(-)-3-(carbamoymethyl)-5-methyl hexanoic acid |
|
Pregabarin |
| 4-tert-butyl benzenesulfonamide (4-TBBSA) |
6292-59-7 |
Bosentan |
